Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease

NCT00314795 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Chronic Kidney Disease
Chronic Renal Failure
Pure Red Cell Aplasia

Interventions

DRUG: Peginesatide

Sponsor

Takeda